Publication

Article

Supplements and Featured Publications

Long-Term Safety and Efficacy of Subcutaneous Immunoglobulin IgPro20 in Chronic Inflammatory Demyelinating Polyneuropathy
Volume

Long-Term Safety and Efficacy of Subcutaneous Immunoglobulin IgPro20 in Chronic Inflammatory Demyelinating Polyneuropathy

This AJMC® Clinical Brief provides key information regarding a study by van Schaik et al, the results of which were originally published in Neurology Neuroimmunology & Neuroinflammation (doi:10.1212/NXI.0000000000000590). The authors of the original publication are Ivo N. van Schaik, MD; Orell Mielke, MD; Vera Bril, MD; Nan van Geloven, PhD; Hans-Peter Hartung, MD; Richard A. Lewis, MD; Gen Sobue, MD; John-PhilipLawo, Diplom; Michaela Praus, Diplom; Billie L. Durn, BS; David R. Cornblath, MD; and Ingemar S. J. Merkies, MD; the PATH study group.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo